CIITA and glioblastoma: In order to study the effect of CIITA on the HLA ligandome of GBM cells, we first characterized cell surface expression of HLA-I and HLA-II with flow cytometry in three patient-derived primary GBM cell lines: HROG02, HROG17, and RA.